What is the risk of transmission of HIV, hepatitis B, and hepatitis C from a needle‑stick injury occurring during central venous line (CVL) suture fixation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Transmission Risk from Needle-Stick Injury During CVL Suture Fixation

The risk of bloodborne virus transmission from a needle-stick injury during central line suturing is low but varies significantly by pathogen: approximately 0.3% for HIV, up to 30% for hepatitis B (if the source patient is HBeAg-positive and you are unvaccinated), and approximately 0.75% for hepatitis C.

HIV Transmission Risk

The risk of HIV transmission after percutaneous exposure to HIV-infected blood is approximately 0.3% (95% CI: 0.2%-0.5%) per single exposure 1. Some guidelines cite a slightly higher figure of 0.36% 2. This relatively low risk should not create complacency—immediate post-exposure prophylaxis (PEP) within 2 hours significantly reduces transmission risk further 1.

Hepatitis B Transmission Risk

Hepatitis B poses the highest transmission risk among bloodborne pathogens. Without prophylaxis, the risk can exceed 30% after a single needlestick exposure to HBeAg-positive hepatitis B infected blood 2. This dramatically high rate explains why:

  • All healthcare workers performing invasive procedures must be vaccinated against hepatitis B 2
  • If you are fully immunized with documented antibody response, your transmission risk is virtually zero 2
  • Antibody levels matter: those with levels >100 IU have robust protection, while levels of 10-100 IU require booster doses 2

Hepatitis C Transmission Risk

The hepatitis C transmission risk is approximately 0.75% (range 0-10.3%) based on analysis of 6,956 needlestick injuries 3. European data suggests even lower rates around 0.42%, while Eastern Asian data shows higher rates around 1.5% 3. Recent prospective data from 2020 showed zero HCV transmissions among 112 high-risk needlestick injuries with proper follow-up 4.

Important caveat: The commonly cited 3% HCV transmission risk is outdated and based on older studies with less sensitive testing 3.

Critical Action Steps After Exposure

Immediate Management (First 2 Hours)

  • Flush and disinfect the wound immediately—98.3% of healthcare workers in one study did this 4
  • For HIV exposure: initiate PEP within 2 hours (85.1% compliance in one study, with another 12.8% starting within 10 hours) 4
  • Determine source patient's infection status urgently

Follow-Up Protocol

  • Attend all follow-up appointments (97.4% compliance reported) 4
  • Baseline and serial testing for HIV, HBV, and HCV
  • Expert consultation for exposure management 1

Context-Specific Considerations for CVL Suturing

During central line suture fixation, you're using a curved needle through skin—this is a hollow-bore or solid suture needle exposure. The actual volume of blood transferred is typically minimal compared to hollow-bore needle injuries from blood draws or IV placement, which may slightly reduce transmission risk, though this distinction is not well-quantified in the literature.

Prevention Strategies

The best approach is prevention:

  • Ensure hepatitis B vaccination with documented antibody response
  • Never pass sharps hand-to-hand 2
  • Never guide needles with fingers 2
  • Use needle drivers appropriately
  • Maintain awareness of needle location at all times
  • Consider using safety-engineered devices when available

Psychological Impact

Recognize that three-quarters of healthcare workers feel concerned after needlestick injuries, and 12.2% report being very concerned 4. This anxiety is normal and underscores the importance of proper counseling and support during follow-up.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.